BOSTON SCIENTIFIC RECEIVES FDA APPROVAL FOR SYNERGY BIOABSORBABLE POLYMER DRUG-ELUTING STENT SYSTEM New Category of Drug-Eluting Stent Approved For U.S. Patients. PR Newswire MARLBOROUGH, Mass. (October 5, 2015) Boston Scientific (NYSE: BSX) has received U.S.
Posted: 2015-10-05 13:03:00